94 related articles for article (PubMed ID: 8604004)
1. Endogenously produced urokinase amplifies tumor necrosis factor-alpha secretion by THP-1 mononuclear phagocytes.
Sitrin RG; Shollenberger SB; Strieter RM; Gyetko MR
J Leukoc Biol; 1996 Feb; 59(2):302-11. PubMed ID: 8604004
[TBL] [Abstract][Full Text] [Related]
2. Urokinase expression in mononuclear phagocytes: cytokine-specific modulation by interferon-gamma and tumor necrosis factor-alpha.
Gyetko MR; Shollenberger SB; Sitrin RG
J Leukoc Biol; 1992 Mar; 51(3):256-63. PubMed ID: 1311745
[TBL] [Abstract][Full Text] [Related]
3. The THP-1 cell line is a urokinase-secreting mononuclear phagocyte with a novel defect in the production of plasminogen activator inhibitor-2.
Gross TJ; Sitrin RG
J Immunol; 1990 Mar; 144(5):1873-9. PubMed ID: 2307845
[TBL] [Abstract][Full Text] [Related]
4. Cytokine-specific regulation of urokinase receptor (CD87) expression by U937 mononuclear phagocytes.
Sitrin RG; Todd RF; Mizukami IF; Gross TJ; Shollenberger SB; Gyetko MR
Blood; 1994 Aug; 84(4):1268-75. PubMed ID: 8049441
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of cell-surface-associated plasminogen activation in cultured keratinocytes by interleukin-1 beta and tumor necrosis factor-alpha.
Bechtel MJ; Reinartz J; Rox JM; Inndorf S; Schaefer BM; Kramer MD
Exp Cell Res; 1996 Mar; 223(2):395-404. PubMed ID: 8601416
[TBL] [Abstract][Full Text] [Related]
6. Tumor necrosis factor regulation of endothelial cell extracellular proteolysis: the role of urokinase plasminogen activator.
Niedbala MJ; Stein-Picarella M
Biol Chem Hoppe Seyler; 1992 Jul; 373(7):555-66. PubMed ID: 1381189
[TBL] [Abstract][Full Text] [Related]
7. Modulation of urokinase-type plasminogen activator gene expression by inflammatory cytokines in human pre-B lymphoma cell line RC-K8.
Niiya K; Shinbo M; Ozawa T; Hayakawa Y; Sakuragawa N
Thromb Haemost; 1995 Dec; 74(6):1511-5. PubMed ID: 8772229
[TBL] [Abstract][Full Text] [Related]
8. THP-1 macrophage membrane-bound plasmin activity is up-regulated by transforming growth factor-beta 1 via increased expression of urokinase and the urokinase receptor.
Falcone DJ; McCaffrey TA; Mathew J; McAdam K; Borth W
J Cell Physiol; 1995 Aug; 164(2):334-43. PubMed ID: 7622580
[TBL] [Abstract][Full Text] [Related]
9. Urokinase regulates embryonic cardiac cushion cell migration without converting plasminogen.
Gorny KN; Brauer PR
Anat Rec; 1999 Nov; 256(3):269-78. PubMed ID: 10521785
[TBL] [Abstract][Full Text] [Related]
10. The kringle domain of urokinase-type plasminogen activator potentiates LPS-induced neutrophil activation through interaction with {alpha}V{beta}3 integrins.
Kwak SH; Mitra S; Bdeir K; Strassheim D; Park JS; Kim JY; Idell S; Cines D; Abraham E
J Leukoc Biol; 2005 Oct; 78(4):937-45. PubMed ID: 16033814
[TBL] [Abstract][Full Text] [Related]
11. Urinary trypsin inhibitor efficiently inhibits urokinase production in tumor necrosis factor-stimulated cells.
Kobayashi H; Gotoh J; Terao T
Eur J Cell Biol; 1996 Dec; 71(4):380-6. PubMed ID: 8980909
[TBL] [Abstract][Full Text] [Related]
12. Tumor necrosis factor α stimulates expression and secretion of urokinase plasminogen activator in human dental pulp cells.
Narita T; Muromachi K; Kamio N; Nakao S; Matsushima K; Hashizume H
J Oral Sci; 2012; 54(4):329-36. PubMed ID: 23221158
[TBL] [Abstract][Full Text] [Related]
13. Urokinase-type plasminogen activator potentiates lipopolysaccharide-induced neutrophil activation.
Abraham E; Gyetko MR; Kuhn K; Arcaroli J; Strassheim D; Park JS; Shetty S; Idell S
J Immunol; 2003 Jun; 170(11):5644-51. PubMed ID: 12759445
[TBL] [Abstract][Full Text] [Related]
14. Induction of TNF-alpha, uPA, IL-8 and MCP-1 by doxorubicin in human lung carcinoma cells.
Niiya M; Niiya K; Kiguchi T; Shibakura M; Asaumi N; Shinagawa K; Ishimaru F; Kiura K; Ikeda K; Ueoka H; Tanimoto M
Cancer Chemother Pharmacol; 2003 Nov; 52(5):391-8. PubMed ID: 12908082
[TBL] [Abstract][Full Text] [Related]
15. U937 cells can utilize plasminogen activator to regulate human interferon-gamma.
Parmely MJ; Sterner KE; Gale A; Zhou WW
J Interferon Res; 1993 Dec; 13(6):397-406. PubMed ID: 8151133
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of urokinase-type plasminogen activator (uPA), its receptor (uPA-R), and inhibitor type-2 (PAI-2) during differentiation of keratinocytes in an organotypic coculture system.
Schaefer BM; Stark HJ; Fusenig NE; Todd RF; Kramer MD
Exp Cell Res; 1995 Oct; 220(2):415-23. PubMed ID: 7556451
[TBL] [Abstract][Full Text] [Related]
17. Receptor-mediated regulation of plasminogen activator function: plasminogen activation by two directly membrane-anchored forms of urokinase.
Vines DJ; Lee SW; Dichek DA; Ellis V
J Pept Sci; 2000 Sep; 6(9):432-9. PubMed ID: 11016879
[TBL] [Abstract][Full Text] [Related]
18. Protein kinase C synergistically stimulates tumor necrosis factor-alpha-induced secretion of urokinase-type plasminogen activator in human dental pulp cells.
Hashizume H; Kamio N; Nakao S; Matsushima K; Sugiya H
J Physiol Sci; 2008 Feb; 58(1):83-6. PubMed ID: 18177545
[TBL] [Abstract][Full Text] [Related]
19. Plasminogen activator inhibitor-1 potentiates LPS-induced neutrophil activation through a JNK-mediated pathway.
Kwak SH; Wang XQ; He Q; Fang WF; Mitra S; Bdeir K; Ploplis VA; Xu Z; Idell S; Cines D; Abraham E
Thromb Haemost; 2006 May; 95(5):829-35. PubMed ID: 16676075
[TBL] [Abstract][Full Text] [Related]
20. Protein kinase C mediates up-regulation of urokinase and its receptor in the migrating keratinocytes of wounded cultures, but urokinase is not required for movement across a substratum in vitro.
Ando Y; Jensen PJ
J Cell Physiol; 1996 Jun; 167(3):500-11. PubMed ID: 8655604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
